With COVID Vaccines on the Horizon, U.S. Urged to Help Ensure Equitable Distribution Across Globe

As the U.S. COVID-19 death toll nears 250,000, drugmakers Pfizer and Moderna have both announced promising vaccine trial results showing over 90% effectiveness in preventing illness. But officials and health experts warn widespread distribution of a vaccine for the coronavirus - which has killed 1.2 million people across the globe - will be tremendously difficult to store and distribute. Vaccine researcher Dr. Saad Omer calls the recent news reassuring" but says drugmakers need to be much more transparent about their data and issue more than just press releases. There should be a little bit more detail, and it should be in the form of some scientific report," says Dr. Omer, director of the Yale Institute for Global Health and professor of infectious diseases at Yale School of Medicine.